• 2016

Company Description

In-silico development of enzymes for pharma

EnzBond is an innovative start-up that aims to change the current understanding of biocatalysis. EnzBond has developed an automated In Silico platform that allows rapid optimization of enzymes used for the production of small molecules. Its proprietary technology allows consumers to drop the enzyme discovery cost >10x compared to the current market leaders and compress the discovery time to days.